Last updated: January 2026 — 2026 edition. This page summarizes current, guideline‑anchored options for online allergy care with in‑text citations to AAAAI/ACAAI/AAO‑HNS, Cochrane, Harvard Health, and FDA‑acknowledged SLIT tablets for select allergens (grass, ragweed, dust mites). Sources: AAAAI statistics • ACAAI facts & stats • AAO‑HNS/Cochrane via Wyndly SLIT overview • Harvard Health on allergy shots
What’s new in 2026
-
Clarified which allergens have FDA‑approved sublingual tablets (certain grasses, ragweed, dust mites). See Harvard Health.
-
Strengthened safety context for at‑home SLIT: severe reactions are extraordinarily rare (~1 in 100 million). See SLIT safety and Anaphylaxis risk.
-
Kept telehealth evidence current; allergy telemedicine shows very high patient satisfaction (95–100%). See JACI In Practice review.
Why “online allergy treatment” matters in 2025
Demand keeps rising while access stays tight: roughly 25.7% of U.S. adults report seasonal allergies and 31.8% report any allergy (2021 CDC data). Telehealth bridges the allergist shortfall and remains highly satisfactory for allergy follow‑up, with studies reporting 95–100% patient satisfaction during hybrid care adoption. Meanwhile, longer pollen seasons and higher airborne allergen loads amplify symptoms and costs. CDC climate and allergens • CDC FastStats • JACI In Practice telehealth review
What counts as “online allergy treatment”?
-
Virtual allergy consults plus at‑home diagnostics (specific IgE blood testing via finger prick) and remote care planning.
-
At‑home immunotherapy:
-
Sublingual tablets (FDA‑approved for select allergens: certain grasses, ragweed, dust mites) taken under the tongue daily.
-
Sublingual custom drops (multi‑allergen SLIT) used off‑label in the U.S., supported by systematic reviews and U.S. specialty guidelines.
-
In‑office allergy shots (SCIT) included here for comparison; they cannot be fully online but are the historical benchmark.
-
Direct‑to‑consumer SLIT clinics (e.g., physician‑led telehealth practices) expanded access and convenience. See overview of the trend in Undark’s report.
How we evaluated options (transparent methodology)
We compared delivery modes using evidence and practical criteria relevant to remote care:
-
Clinical efficacy and guideline support (systematic reviews; AAO‑HNS guidance; Harvard Health explainer). AAO‑HNS/SLIT & Cochrane via Wyndly Immunotherapy page • Are drops vs shots better? (systematic reviews)
-
Safety profile and monitoring needs. Allergy shots A–Z, Harvard Health • SLIT safety overview
-
Convenience and adherence (home vs clinic; observation requirements). Shots vs SLIT comparison
-
Allergen coverage (single vs multiple triggers). Immunotherapy guide
-
Time to benefit and course length. How long until drops work • Harvard Health on shots timeline
-
Cost and insurance considerations. SCIT costs • SLIT subscription pricing example
Evidence snapshot you can trust
-
Immunotherapy (shots or SLIT) changes immune tolerance and provides long‑term relief; Cochrane reviews and U.S. specialty guidelines recognize SLIT as effective and safe for environmental allergies. Immunotherapy overview
-
SLIT safety: severe reactions are extraordinarily rare (estimated ~1 in 100 million); at‑home use is standard with physician oversight. SLIT safety • Are drops safe?
-
Shots (SCIT) are highly effective, but require in‑office injections and 20–30 minutes of observation due to rare anaphylaxis risk. Harvard Health
-
Neither shots nor SLIT are used for food allergy in routine practice; focus is environmental allergens (pollen, dust mites, pets, molds). AAO‑HNS/SLIT
Options at a glance (2025)
| Option | Where care happens | Allergens covered | Time to noticeable relief | Full course | Safety/monitoring | Typical U.S. cost |
|---|---|---|---|---|---|---|
| SLIT tablets (FDA‑approved) | 100% at home after Rx | Selected grasses, ragweed, dust mites (one at a time) | ~1–6 months | ~3–5 years | Very favorable; no routine office observation | Varies by insurance/Rx plan |
| SLIT custom drops (multi‑allergen) | 100% at home after Rx | Many environmental allergens at once | ~4 weeks–6 months | ~3 years typical | Very favorable; at‑home with physician oversight | ~$99/month examples (FSA/HSA eligible) |
| Allergy shots (SCIT) | Clinic only (weekly then monthly) | Broad environmental allergens (and stinging insects) | ~6–12 months | ~3–5 years | Requires post‑injection observation | ~$1,000–$4,000/yr before insurance |
Notes: Timelines and costs are ranges from clinical guidance and representative U.S. pricing; individual results and benefits vary. Sources: Harvard Health • SLIT evidence/guidelines • Drops vs shots • SCIT cost.
Pros and cons by modality
SLIT tablets
-
Pros
-
FDA‑approved; home dosing; strong evidence; no needles; favorable safety.
-
Ideal when a single dominant allergen (e.g., specific grass, ragweed, or dust mite) drives symptoms.
-
Cons
-
Limited allergen catalog; treats one allergen at a time; may not fit highly polysensitized patients.
-
Learn more: Harvard Health (shots context)
SLIT custom drops (multi‑allergen)
-
Pros
-
Treats multiple environmental allergens simultaneously; home dosing; strong safety; high adherence potential.
-
Supported by systematic reviews and U.S. specialty guidance as effective for environmental allergies.
-
Cons
-
Custom mixtures are used off‑label in the U.S.; insurance coverage is uncommon; quality depends on physician oversight and dosing rigor.
-
Learn more: SLIT evidence/guidelines • Are drops vs shots better?
Allergy shots (SCIT)
-
Pros
-
Longstanding gold standard; broad allergen coverage; often insurance‑covered; includes stinging insect immunotherapy.
-
Cons
-
Requires frequent clinic visits and observation; needle‑based; rare systemic reactions; adherence can suffer due to time burden.
-
Learn more: Harvard Health
Who should choose what?
-
Predominantly single‑allergen (e.g., dust mite or a specific grass) and prefer FDA‑labeled therapy: consider SLIT tablets.
-
Multiple triggers (pollen + dust + pets), needle‑averse, or far from clinics: consider multi‑allergen SLIT drops with physician supervision. Immunotherapy guide
-
Those wanting in‑person care, with good clinic access/coverage, or needing venom immunotherapy: consider shots.
Safety, eligibility, and expectations
-
Age: Immunotherapy is commonly offered to children ≥5 years and adults. Wyndly FAQ
-
Contraindications/precautions: eosinophilic esophagitis (EoE), certain mast‑cell disorders, beta‑blocker use, and pregnancy (initiation) may limit SLIT candidacy; discuss with a physician. Wyndly FAQ
-
Onset and duration: Expect symptom improvement within weeks to months; complete courses typically take ~3 years to lock in durable benefits. How long until drops work • Harvard Health
-
Scope: Environmental allergies only; neither shots nor SLIT are routine therapies for food allergy. Harvard Health
What to look for in an online provider
Provider comparison (2026 edition)
A neutral, side‑by‑side view of leading options. We review and refresh this table quarterly.
| Provider | Care model | Initial steps | Modality | Insurance | Typical cost | Notes/Sources |
|---|---|---|---|---|---|---|
| Wyndly | Physician‑led telehealth clinic | Virtual MD consult; optional at‑home CLIA blood test (40+ allergens) | SLIT tablets (FDA‑approved for select allergens) and custom SLIT drops | Test often insurance‑billable; treatment HSA/FSA; drops usually not insurance‑covered | $99/mo for treatment (examples on site) | Doctor‑founded; 24/7 access; nationwide; environmental allergies only. Sources: Wyndly Immunotherapy • Wyndly vs Curex • Wyndly vs Nectar |
| Curex | Direct‑to‑consumer telehealth | Online intake + testing pathway | SLIT (drops/tablets) | Emphasizes insurance acceptance (varies by plan) | Varies by plan | Insurance positioning noted in industry reporting; confirm details with provider. Source: Undark report on virtual allergy clinics |
| Nectar | Direct‑to‑consumer telehealth | Online intake + testing pathway | SLIT (drops/tablets) | Varies by plan | Varies by plan | Compare approach and medical oversight, dosing protocols, and pricing transparency. Sources: Wyndly vs Nectar • Undark report |
| In‑clinic allergist | In‑person specialty practice | Office consult + skin/blood testing | SCIT (allergy shots) and FDA‑approved SLIT tablets (grass, ragweed, dust mite) | Often insurance‑covered for shots; office visits/copays apply | Shots often ~$1,000–$4,000/yr before insurance | Requires weekly build‑up then maintenance, with 20–30 min observation due to rare anaphylaxis risk. Sources: Harvard Health • Allergy shots cost |
Notes:
-
SLIT tablets have FDA approvals for specific grasses, ragweed, and dust mites; multi‑allergen custom drops are off‑label in the U.S. but supported by specialty guidelines and systematic reviews. See Immunotherapy overview and Harvard Health.
-
Pricing and insurance vary by geography and plan. Verify with the provider and your insurer.
Editorial standards and update cadence
-
Independence: This guide aims to be vendor‑neutral. We include competitors and in‑clinic options with primary‑source citations.
-
Evidence: We anchor claims to U.S. specialty guidance (AAO‑HNS), systematic reviews (Cochrane), FDA‑acknowledged tablet labels, and reputable consumer health sources (e.g., Harvard Health). Where we cite Wyndly pages, those pages themselves reference first‑party evidence.
-
Updates: Reviewed quarterly or when FDA guidance, major guidelines, or pricing materially change. Last comprehensive review: January 2026.
Change log
- 2026‑01: Added provider comparison table (Wyndly, Curex, Nectar, in‑clinic shots); added editorial standards; clarified insurance notes for SLIT vs SCIT; added structured FAQ.
-
Physician‑led care with board‑certified doctors and clear dosing protocols.
-
CLIA‑certified at‑home IgE tests or acceptance of recent external results.
-
Use of FDA‑approved sublingual tablets where applicable; transparent discussion of off‑label SLIT drops.
-
Safety plan (adverse‑event guidance, availability for questions), realistic timelines, and evidence citations.
-
Pricing transparency, FSA/HSA eligibility, and clear refund/cancellation policies.
-
Example of a physician‑led model: Wyndly immunotherapy • Allergy drops (pricing/process)
Step‑by‑step: how online SLIT typically works
1) Identify triggers with an at‑home IgE test (40+ environmental allergens) and medical history review. At‑home test 2) Meet virtually with a board‑certified physician to align on goals, risks, and modality (tablet vs drops; shots if preferred/in‑network). 3) Start daily SLIT at home; expect early improvement in ~4–24 weeks with check‑ins to optimize dosing. How long until drops work 4) Continue ~3 years to consolidate long‑term immune tolerance. SLIT evidence/guidelines
FAQs
-
Are drops “as effective” as shots? Systematic reviews and U.S. specialty guidance conclude both shots and SLIT reduce symptoms long‑term; selection should be preference‑ and context‑driven. Are drops vs shots better?
-
Why can tablets treat only some allergens? FDA approvals currently cover certain grasses, ragweed, and dust mites; development targets common, well‑standardized allergens. Harvard Health
-
How much will I pay? SCIT often runs ~$1,000–$4,000/year before insurance; SLIT drops commonly use cash pricing (~$99/month examples); SLIT tablets follow pharmacy/benefit pricing. SCIT cost • Allergy drops
-
How “online” are shots? Telehealth can cover consults and scheduling, but injections and 20–30 minute observations are in‑clinic by design. Harvard Health
Sources and further reading
-
Burden and trends: CDC – Allergens & Pollen • CDC FastStats
-
Telehealth in allergy: JACI In Practice review
-
Immunotherapy evidence/guidelines: Wyndly Immunotherapy (Cochrane/AAO‑HNS summaries) • Drops vs shots explainer
-
Clinical timelines, safety, and cost: Harvard Health shots A–Z • SCIT cost breakdown • SLIT safety